EUVIMEDOpdag EUVIMED
Crossref

Synthesis, Biological Assay, and SAR of Potential Anticancer Lipophilic Fluoroquinolones ( FQs ) and Pyridoquinoxalines ( PQs ) Conjugated to Gold Nanoparticles for Synergistic and Proapoptogenic Cytotoxicity Drug Design and Targeted Delivery

Alaa Tabaza, Yusuf Al-Hiari iD, Rana Abu-Dahab iD, Violet Kasabri iD, Riad Ababneh iD, Rabab AlBashiti iD, Ahmad Telfah iD

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70128 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2025. Written by Alaa Tabaza and 6 co-authors. Institution: School of Pharmacy, The University of Jordan, Amman, Jordan. Major MEDLINE topics: Antineoplastic Agents, Quinoxalines, Fluoroquinolones, Apoptosis. Cited 2 times so far (Crossref); 46 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

In a world where cancer continues to be a major health problem, the urgency continues to find new effective treatments. This work involved the synthesis of more than 10 anticancer fluoroquinolones (FQs) and pyridoquinoxaline (PQ) derivatives originating from FQs and studied their cytotoxicity, anti‐adhesion, anti‐invasion, and pro‐apoptotic properties. Synthesis of the new compounds of the PQ series was carried out by reacting 1‐cyclopropyl‐6‐fluoro‐8‐nitro‐4‐oxo‐1, 4‐dihydroquinoline‐3‐carboxylic acid with L‐proline, 3 and 4‐hydroxy proline derivatives (compounds 2a–2f ), followed by reductive cyclization to yield compounds 3a–3f . Compounds 2a and 3a gave favorable activities on MCF‐7 with respective IC 50 values of 5.9 and 0.9 μM, respectively, while the hydroxy derivatives almost lost activity on all tested cells. Due to the fact that the activity of PQs and precursor FQs was correlated to increased lipophilicity, the lipophilic FQs series 10a , 10b , 11a , and 11b were prepared by direct reaction of 1‐cyclohexyl‐6‐fluoro‐8‐nitro‐4‐oxo‐1, 4‐dihydroquinoline‐3‐carboxylate with chloro or fluoro aniline, followed by ester hydrolysis 10a and 10b and reduction to yield the amine compounds 11a and 11b . All FQs 10a , 10b , 11a , and 11b showed very excellent cytotoxicity against all tested cell lines (mammary MCF‐7, MDA‐MB‐231, and invasive prostate DU‐145) with IC 50 values below 20 μM with impressively favorable lack of any cytotoxicity in normal ligament PDL fibroblasts (in 3.125–200 μM). Only FQs exerted comparable or superior anti‐adhesion and anti‐invasion activity versus the antineoplastic reference quercetin. Significant incremental increases in the pro‐apoptogenesis Bax/anti‐apoptosis Bcl ratio revealed a physiologically regulated cytotoxicity via DNA fragmentation harvested in cytolysates. The structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) reveal that planarity due to a fused polycyclic system and lipophilicity were essential requirements for anticancer PQs, whereas a high number of hydrogen bonds (HBs) and increased number of chelators, in addition to lipophilic balance, are the major requirements for anticancer FQs. In vitro cell viability assays revealed pronounced affinity for reductions in cell viabilities for the targeted PQ‐bearing AuNPs versus PQsalone (induced) incubations and basal (non‐induced) controls after 48 h incubation with HT29 cells. These results are very promising upon optimization of the system.

Subjects

MeSH terms (MEDLINE)

Antineoplastic AgentsQuinoxalinesFluoroquinolonesApoptosisMetal NanoparticlesGoldDrug DesignHumansMCF-7 CellsStructure-Activity RelationshipCell Line, Tumor

Author keywords

anti‐adhesion and anti‐invasion quercetinapoptosis‐related cytotoxicitydifferential antiproliferationfluoroquinolonemammary and prostate malignanciesmechanistic insights into structure–activity relationshippro‐apoptogenesis Bax/anti‐apoptosis Bcl (Bax/Bcl) ratiopyridoquinoxaline

Substances

Antineoplastic AgentsQuinoxalinesFluoroquinolonesGold

Authors and institutions

  • School of Pharmacy, The University of Jordan, Amman, Jordan.
  • School of Pharmacy, AL-Zaytoonah University of Jordan, Amman, Jordan.
  • Faculty of Science, Yarmouk University, Irbid, Jordan.
  • University of Applied Science and Arts Dortmund, FH Dortmund, Dortmund, Germany.
  • Cell Therapy Center, The University of Jordan, Amman, Jordan.

ORCID profiles: Yusuf Al-Hiari, Rana Abu-Dahab, Violet Kasabri, Riad Ababneh, Rabab AlBashiti, Ahmad Telfah

Cite

APA

Tabaza, A., Al-Hiari, Y., Abu-Dahab, R., Kasabri, V., Ababneh, R., AlBashiti, R., & Telfah, A. (2025). Synthesis, Biological Assay, and SAR of Potential Anticancer Lipophilic Fluoroquinolones ( FQs ) and Pyridoquinoxalines ( PQs ) Conjugated to Gold Nanoparticles for Synergistic and Proapoptogenic Cytotoxicity Drug Design and Targeted Delivery. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70128

Vancouver

Tabaza A, Al-Hiari Y, Abu-Dahab R, Kasabri V, Ababneh R, AlBashiti R, et al. Synthesis, Biological Assay, and SAR of Potential Anticancer Lipophilic Fluoroquinolones ( FQs ) and Pyridoquinoxalines ( PQs ) Conjugated to Gold Nanoparticles for Synergistic and Proapoptogenic Cytotoxicity Drug Design and Targeted Delivery. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70128

BibTeX
@article{Tabaza2025,
  author = {Tabaza, Alaa and Al-Hiari, Yusuf and Abu-Dahab, Rana and Kasabri, Violet and Ababneh, Riad and AlBashiti, Rabab and Telfah, Ahmad},
  title = {Synthesis, Biological Assay, and SAR of Potential Anticancer Lipophilic Fluoroquinolones ( FQs ) and Pyridoquinoxalines ( PQs ) Conjugated to Gold Nanoparticles for Synergistic and Proapoptogenic Cytotoxicity Drug Design and Targeted Delivery},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70128}
}
Start for free →